Albuminuria and CKD: Tackling the Silent Marker with SGLT2 Inhibitor
Mar
19
06:00 PM
Albuminuria is a critical early marker of kidney damage and a predictor of CKD progression. Despite its clinical significance, it often remains undetected until irreversible damage has occurred. Recent advancements highlight the role of SGLT2 inhibitors .in reducing albuminuria, slowing CKD progression, and improving cardiovascular outcomes.
Panelists
Dr.Tanmay Pandya
Director and Head of Department of Nephrology and Renal Transplantation Sarvodaya Hospital and Research Centre, Faridabad
Sponsers
Albuminuria and CKD: Tackling the Silent Marker with SGLT2 Inhibitor
Mar
19
06:00 PM
Albuminuria is a critical early marker of kidney damage and a predictor of CKD progression. Despite its clinical significance, it often remains undetected until irreversible damage has occurred. Recent advancements highlight the role of SGLT2 inhibitors .in reducing albuminuria, slowing CKD progression, and improving cardiovascular outcomes.
Panelists
Dr.Tanmay Pandya
Director and Head of Department of Nephrology and Renal Transplantation Sarvodaya Hospital and Research Centre, Faridabad
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
